Bumrungrad Hospital PCL
🇹🇭XBKK.BHThailandNot reported
PriceTHB 197.50+1.50 (+0.77%)
Latest anomalies
Very negative 11 detected in the last 120 days
- High: 1
- Medium: 10
- Low: 0
12-1M momentum: flipped sign, from negative to positive
12-1M momentum: flipped sign, from positive to negative
Dividend payout ratio: a sudden spike above its trailing quarter average
Cash conversion cycle: a sudden spike above its trailing quarter average
Days sales outstanding: a sudden spike above its trailing quarter average
Free with a Finzer account.
Profile
- Thailand
Identity
- Type
- Stock
- ISIN
- TH0168A10Z01
- CUSIP
- Not reported
Company
- Employees
- Not reported
- Headquarters
- Germany
- Website
- Not reported
- CEO
- Dr. Artirat Charukitpipat Ph.D.
Market
- Shares outstanding
- 795M
- Market cap
- THB 157.01B
Key dates
- Next earnings
- Nov 12, 2026
Highlights
- Market cap
- Not reported
- EPS LTM
- THB 8.76
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- THB 25.47B+1.69%up year on year
- Net income
- THB 7.6B+2.01%up year on year
- Gross margin
- 51.87%+1.55%up year on year
- Free cash flow
- THB 4.69B-26.75%down year on year
Latest news
News is not sourced for this exchange.
Business summary
Bumrungrad Hospital PCL is listed on Stock Exchange of Thailand (Thailand) under the ticker BH. Its market capitalisation is THB 157.01B, from 795M shares outstanding, as of . Across the 251 trading sessions to the shares traded between THB 136.00 and THB 214.00, and the last close of THB 197.50 sits 79% of the way up that range. The company is led by Dr. Artirat Charukitpipat Ph.D.. The same company also trades as BZ7A on Stuttgart Stock Exchange.
Bumrungrad Hospital Public Company Limited owns and operates hospitals and healthcare centers in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, pediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic, dialysis, radiology and nuclear medicine, digestive disease, ear, nose, throat, emergency, endocrinology, esperance, diabetes, expatriate liaison, eye, fertility, gastrointestinal motility, health screening, holistic wound care, horizon regional cancer, hyperbaric oxygen therapy, nephrology, neuroscience, orthopaedics, perinatal, plastic surgery, pulmonary, refractive surgery, memory, robotic scoliosis, skin, sports medicine and joint, surgery, travel medicine, urology, scientific wellness, skin and aesthetic, and women's centers. The company also operates breastfeeding, Yangon, COVID-19 recovery, IVF, hearing and balance, medical, new life healthy aging, Parkinson's disease and movement disorders, pride, surgery, and vaccine clinics and centers. In addition, it operates spine institute, heart institute, and intensive care unit; and offers nutrition services, pharmacy services, preventive genomics and integrative medicine services. Bumrungrad Hospital Public Company Limited was founded in 1975 and is based in Bangkok, Thailand.